Page 126 - 南京医科大学学报自然科学版
P. 126

第44卷第3期
               ·416 ·                          南   京 医 科       大 学      学 报                        2024年3月


                   scRNA⁃seq and lipidomics reveal aberrant lipid metabo⁃  Commun,2021,12:295
                   lism for early⁃stage diagnosis[J]. Sci Transl Med,2022,  [44] NA F F,PAN X Y,CHEN J Y,et al. KMT2C deficiency

                   14(630):eabk2756                                  promotes small cell lung cancer metastasis through
             [36] ELTAYEB K,LA MONICA S,TISEO M,et al. Reprogram⁃    DNMT3A ⁃ mediated epigenetic reprogramming[J]. Nat
                   ming of lipid metabolism in lung cancer:an overview with  Cancer,2022,3(6):753-767
                   focus on EGFR⁃mutated non⁃small cell lung cancer[J].  [45] YANG Z Y,SONG Z B,CHEN Z J,et al. Metabolic and
                   Cells,2022,11(3):413                              lipidomic characterization of malignant pleural effusion in
             [37] REINA⁃CAMPOS M,DIAZ⁃MECO M T,MOSCAT J. The         human lung cancer[J]. J Pharm Biomed Anal,2020,180:
                   complexity of the serine glycine one ⁃ carbon pathway in  113069
                   cancer[J]. J Cell Biol,2020,219(1):e210907022  [46] PARMA B,WURDAK H,CEPPI P. Harnessing mitochon⁃
             [38] PARK S M,SEO E H,BAE D H,et al. Phosphoserine      drial metabolism and drug resistance in non ⁃ small cell
                   phosphatase promotes lung cancer progression through  lung cancer and beyond by blocking heat⁃shock proteins
                   the dephosphorylation of IRS⁃ 1 and a noncanonical L⁃  [J]. Drug Resist Updat,2022,65:100888
                   serine⁃independent pathway[J]. Mol Cells,2019,42(8):  [47] SUN Z G,ZHANG R,ZHANG X,et al. LINE⁃1 promotes
                   604-616                                           tumorigenicity and exacerbates tumor progression via
             [39] 江换钢,罗      园,钟亚华,等. 丝氨酸转运蛋白 SFXN1                  stimulating metabolism reprogramming in non⁃small cell
                   在非小细胞肺癌中的表达及临床意义[J]. 肿瘤代谢与                        lung cancer[J]. Mol Cancer,2022,21(1):147
                   营养电子杂志,2020,7(3):301-306                     [48] YUN C W,KIM H J,LIM J H,et al. Heat shock proteins:
             [40] MULLEN N J,SINGH P K. Nucleotide metabolism:a pan⁃  agents of cancer development and therapeutic targets in
                   cancer metabolic dependency[J]. Nat Rev Cancer,2023,  anti⁃cancer therapy[J]. Cells,2019,9(1):60
                   23(5):275-294                                [49] KO J C,CHEN J C,HSIEH J M,et al. Heat shock protein
             [41] CHEN X L,JI R,LIU J J,et al. Roles of DNA polymerase  90 inhibitor 17⁃AAG down⁃regulates thymidine phosphory⁃
                   ζ in the radiotherapy sensitivity and oxidative stress of  lase expression and potentiates the cytotoxic effect of
                   lung cancer cells[J]. Cancer Chemother Pharmacol,  tamoxifen and erlotinib in human lung squamous carcino⁃
                   2022,89(3):313-321                                ma cells[J]. Biochem Pharmacol,2022,204:115207
             [42] CRUZ⁃BERMÚDEZ A,LAZA⁃BRIVIESCA R,VICENTE⁃     [50] PILLAI R,FENNELL D,KOVCIN V,et al. PL03.09:
                   BLANCO R J,et al. Cancer⁃associated fibroblasts modify  phase 3 study of ganetespib,a heat shock protein 90 in⁃
                   lung cancer metabolism involving ROS and TGF⁃β signal⁃  hibitor,with docetaxel versus docetaxel in advanced non⁃
                   ing[J]. Free Radic Biol Med,2019,130:163-173      small cell lung cancer(GALAXY⁃2)[J]. J Thorac Oncol,
             [43] LI B T,ZHU L L,LU C L,et al. circNDUFB2 inhibits non  2017,12(1):S7-S8
                   ⁃ small cell lung cancer progression via destabilizing                 [收稿日期] 2023-10-20
                   IGF2BPs and activating anti ⁃ tumor immunity[J]. Nat                        (本文编辑:陈汐敏)
   121   122   123   124   125   126   127   128   129   130   131